Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Musumeci

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cellsMarco Radi, Chiara Brullo, Emmanuele Crespan, et al.
European Journal of Medicinal Chemistry|August 25, 2018
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interactionIlaria D'Agostino, Ilaria Giacchello, Giulio Nannetti, et al.
Journal of Chemical Information and Modeling|June 5, 2014
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffoldFrancesco Ortuso, Rosario Amato, Anna Artese, et al.
Oncotarget|January 18, 2018
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiformeClaudia Abbruzzese, Giada Catalogna, Enzo Gallo, et al.
Chemmedchem|February 26, 2013
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitorsMattia Mori, Cristina Tintori, Robert Selwyne Arul Christopher, et al.
European Journal of Medicinal Chemistry|August 11, 2019
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell linesAnna Lucia Fallacara, Raffaele Passannanti, Mattia Mori, et al.
European Journal of Medicinal Chemistry|October 15, 2024
Applying molecular hybridization to design a new class of pyrazolo[3,4-d]pyrimidines as Src inhibitors active in hepatocellular carcinomaSalvatore Di Maria, Raffaele Passannanti, Federica Poggialini, et al.
Translational Oncology|June 5, 2019
In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug SensitivityLucia D'Antona, Vincenzo Dattilo, Giada Catalogna, et al.
Journal of Medicinal Chemistry|March 30, 2011
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization studyMarco Radi, Elena Dreassi, Chiara Brullo, et al.
Drug Development Research|February 13, 2024
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatmentChiara Vagaggini, Debora Petroni, Ilaria D'Agostino, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cellsMarco Radi, Chiara Brullo, Emmanuele Crespan, et al.
European Journal of Medicinal Chemistry|August 25, 2018
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interactionIlaria D'Agostino, Ilaria Giacchello, Giulio Nannetti, et al.
Journal of Chemical Information and Modeling|June 5, 2014
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffoldFrancesco Ortuso, Rosario Amato, Anna Artese, et al.
Oncotarget|January 18, 2018
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiformeClaudia Abbruzzese, Giada Catalogna, Enzo Gallo, et al.
Chemmedchem|February 26, 2013
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitorsMattia Mori, Cristina Tintori, Robert Selwyne Arul Christopher, et al.
European Journal of Medicinal Chemistry|August 11, 2019
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell linesAnna Lucia Fallacara, Raffaele Passannanti, Mattia Mori, et al.
European Journal of Medicinal Chemistry|October 15, 2024
Applying molecular hybridization to design a new class of pyrazolo[3,4-d]pyrimidines as Src inhibitors active in hepatocellular carcinomaSalvatore Di Maria, Raffaele Passannanti, Federica Poggialini, et al.
Translational Oncology|June 5, 2019
In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug SensitivityLucia D'Antona, Vincenzo Dattilo, Giada Catalogna, et al.
Journal of Medicinal Chemistry|March 30, 2011
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization studyMarco Radi, Elena Dreassi, Chiara Brullo, et al.
Drug Development Research|February 13, 2024
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatmentChiara Vagaggini, Debora Petroni, Ilaria D'Agostino, et al.
Pageof 6